Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TLR7/8 agonist treatment induces an increase in bone marrow resident dendritic cells and hematopoietic progenitor expansion and mobilization

Experimental Hematology(2021)10.1016/j.exphem.2021.02.001Source: DataRank Database

TLR7/8 agonist treatment induces an increase in bone marrow resident dendritic cells and hematopoietic progenitor expansion and mobilization is a research paper published in Experimental Hematology (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.88)OA: bronzeTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Juo-Chin Yao ORCID,Justin T. Li ORCID,Amy P. Schmidt,Daniel C. Link ORCID,Sidan Li ORCID

Live enrichment

PubMed:33556431 PMC:PMC9900459 OpenAlex:https://openalex.org/W3126745994

National Institutes of Health

Grant: RO1HL131655

NHLBI NIH HHS

Grant: R01 HL131655

NCI NIH HHS

Grant: P50 CA171963

NCI NIH HHS

Grant: P01 CA101937

The Henry and Marilyn Taub Foundation

FWCI

0.88

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.exphem.org/article/S0301472X21000333/pdf

publisherhttp://www.exphem.org/article/S0301472X21000333/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0301472X21000333?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0301472X21000333?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.exphem.2021.02.001

Fields of Study

Immunotherapy and Immune ResponsesImmune Response and InflammationHematopoietic Stem Cell TransplantationAnimalsBone Marrow CellsDendritic CellsHematopoiesisHematopoietic Stem CellsImidazolesMiceToll-Like Receptor 7Toll-Like Receptor 8

MeSH Terms

AnimalsBone Marrow CellsDendritic CellsHematopoiesisHematopoietic Stem CellsImidazolesToll-Like Receptor 7Toll-Like Receptor 8Mice

Keywords

Progenitor cellTLR7HaematopoiesisDendritic cellMyeloidBiologyAgonistStem cellBone marrowImmunologyCancer researchToll-like receptorCell biologyImmune systemInnate immune systemReceptor

Sustainable Development Goals

SDG 0: Good health and well-being

TLR7/8 agonist treatment induces an increase in bone marrow resident dendritic cells and hematopoietic progenitor expansion and mobilization

FAIR Checklist

Authors (5)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)